JohnDellacroceMD

Ophthalmology • Fayetteville, AR

Retinal Disease, Uveitis

VitreoRetinal Surgeon/Retina Specialist- Retina Center of Arkansas

Join to view full profile

Dr. Dellacroce is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Dellacroce's full profile

Already have an account?

Office
1794 E Joyce Blvd
Suite 3
Fayetteville, AR 72703
Phone+1 479-234-4499
Is this information wrong?

Summary

Dr. John DellaCroce is a board-certified ophthalmologist and fellowship-trained vitreoretinal microsurgeon who specializes in the treatment of diseases involving the retina, vitreous, and macula. He provides state-of-the-art, high-quality eye care to patients in Northwest Arkansas.

Dr. DellaCroce is highly skilled in the latest surgical techniques for a wide range of eye health issues including retinal detachments, epiretinal membranes (macular pucker), macular holes, retinal tears, diabetic tractional retinal detachments, as well as the treatment of age-related macular degeneration, diabetic retinopathy, retinal vascular occlusions, and many other diseases of the retina and vitreous.

Education & Training

University of Utah HealthFellowship, Surgical Retina and Vitreous, 2006 - 2008
Tulane UniversityResidency, Ophthalmology, 2003 - 2006
Louisiana State University School of MedicineInternship, Internal Medicine, 2002 - 2003
LSU School of Medicine in ShreveportClass of 2002
Louisiana Tech UniversityBS, Biomedical Engineering, magna cum laude, 1994 - 1997

Certifications & Licensure

AR State Medical License 2011 - 2024
LA State Medical License 2003 - 2012
UT State Medical License 2006 - 2012
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

Outstanding Resident Research Presentation Award Tulane Ophthalmology- C.S. O'Brien Professorship Lecture Series, 2006
Commendation Letter on Outstanding Performance- Internal Medicine Clerkship Louisiana State University Health Sciences Center, 2002
Research Grant Biomedical Engineering American Heart Association, 1997
magna cum laude Louisiana Tech University BS Biomedical Engineering, 1997
Best Prototype Award Senior Design Project Biomedical Engineering Dept. Louisiana Tech University, 1997
Phi Kappa Phi Honor Society Louisiana Tech University, 1997
Tau Beta Pi National Engineering Honor Society Louisiana Tech University, 1997
Alpha Eta Mu Beta- Biomedical Engineering Honor Society Louisiana Tech University, 1997
Alpha Epsilon Delta- Premedical Honor Society Louisiana Tech University, 1997
Frank Bogard Memorial Scholarship Louisiana Tech University, 1996
CMS Meaningful Use Stage 1 Certification Medflow EHR, Medflow, Inc., 2012-2013
Join now to see all

Clinical Trials

A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis Start of enrollment: 2007 Jan 01
Completed
Phase 3
A Multi-center Study to Assess the Efficacy and Safety of LX211 in Active Non-infectious Anterior Uveitis Start of enrollment: 2007 Jan 01
Completed
Phase 3
A Study of an Encapsulated Cell Technology (ECT) Implant for Patients With Atrophic Macular Degeneration Start of enrollment: 2007 Jan 01
Completed
Phase 2
A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pigmentosa Start of enrollment: 2007 Jan 01
Completed
Phase 2
A Study of Encapsulated Cell Technology (ECT) Implant for Patients With Late Stage Retinitis Pigmentosa Start of enrollment: 2007 Jan 01
Completed
Phase 2
Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD) Start of enrollment: 2011 Sep 01
Completed
Phase 2
A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy Start of enrollment: 2015 Mar 30
Completed
Phase 2
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration Start of enrollment: 2015 Jun 24
Terminated
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema Start of enrollment: 2018 Oct 09
Completed
Phase 3
Efficacy and Safety Trial of Conbercept Intravitreal Injection for Neovascular AMD (PANDA-2) Start of enrollment: 2018 Dec 21
Terminated
Phase 3
A Study to Evaluate the Efficacy and Safety of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate, Versus Aflibercept in Patients With Neovascular (Wet) Age-Related Macular Degeneration. Start of enrollment: 2019 Sep 30
Terminated
Phase 2, Phase 3
Join now to see all

Publications & Presentations

PubMed

44 citations
Hypertension and the eye.
John T DellaCroce, Albert T. Vitale> ;Current Opinion in Ophthalmology. 2008 Nov 1
2 citations
Serous retinal detachment following glaucoma surgery.
J.T. Dellacroce, Jessica Laursen, Ramesh S. Ayyala> ;Ophthalmic Surgery, Lasers & Imaging. 2007 Nov 1
Inhibition of corneal angiogenesis by ascorbic acid in the rat model.
Peyman, G. A., Kivilcim, M., Morales, A. M., DellaCroce, J. T., Conway, M. D.> ;Graefes Arch Clin Exp Ophthalmol. 2007 Oct
Triamcinolone acetonide in ocular therapeutics.
Jermak, C. M., Dellacroce, J. T., Heffez, J., Peyman, G. A.> ;Surv Ophthalmol. 2007 Sep 01
12 citations
Diagnostic & therapeutic challenges. Tamoxifen toxicity.
Paul S. Bernstein, John T DellaCroce> ;Retina. 2007 Sep 1
20 citations
Intravitreal toxicity of high-dose etanercept.
Muhamet Kivilcim, Gholam A. Peyman, Abdul Ahad Kazi, John T DellaCroce, Randa N. Ghobrial, Roberta Monzano> ;Journal of Ocular Pharmacology and Therapeutics. 2007 Mar 6
1 citations
Removal of submacular exudates in a patient with coats disease: a case report.
Gholam A. Peyman, John T DellaCroce, Shehab A. Ebrahim> ;Retina. 2006 Sep 1
4 citations
Intravitreal toxicity of garenoxacin.
Mohammad Riazi Esfahani, Abdul Ahad Kazi, Gholam A. Peyman, John T DellaCroce, Erdinç Aydin> ;Retina. 2006 Feb 1
Join now to see all